NYSE: STE

STERIS plc (Ireland) (STE) Stock Analysis & Forecast

Nov 13 close

$264.32+10.88 (+4.3%)

Gekko Brief

AI summaryNov 9 close

STERIS raised its fiscal 2027 adjusted EPS guidance to $11.35-$11.55 after second-quarter results showed adjusted EPS rising 19% to $2.94, helped by a $20 million tariff refund and strong Life Sciences equipment shipments, even as the sterilization business started slower. KeyCorp raised its price target on the stock to $284.00 from $269.00, maintaining an "overweight" rating. The company also filed a Form 424B5 and a Form S-3ASR, along with a mixed shelf offering covering debt securities, ordinary shares, preferred shares, warrants and units.

STE closed at $256.94, up 1.8%, sitting above both its 50-day average of $221.04 and 200-day average of $224.22. The stock's one-month return stands at 19.8%, with a six-month return of 27.3%, though the one-year return is -1.2%. The GekkoIndex reads 40.8, placing the stock in the Distribution zone, down 9.4 over the last five readings. Price sits just 0.6% above Gekko Fair Value of $255.40.

The next earnings date falls on 3 February 2027, 80 days away, placing it outside a typical 20-trading-day holding window. Over the last 90 days, Congress recorded 1 buy and 0 sells in the stock. Analyst coverage from 3 firms shows 3 buy ratings and a consensus target of $260.71, implying 1.5% upside. Seasonality data over 5 years shows the next 20 trading days from this point averaging -0.5%, with gains in 1 of those years, a pattern worth noting given the stock's typical 20-day move of 4.4%.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

STERIS plc (Ireland) price vs fair value

$264.32$250.51Nov ’25May ’26Nov ’26
Close $264.32200-day averageGekko Fair Value $250.51

STERIS plc (Ireland) quick facts

Market cap
$25.67B
P/E ratio
30.4
Forward P/E
22.5
EPS, TTM
$8.34
Revenue, TTM
$6.17B
Profit margin
13.4%
Dividend yield
1.01%
Beta
0.86
Volume
976,381 avg 864,236
1-year return
−1.4%
Typical daily move
±2.9%
Typical 20-day move
±4.4%
50-day average
$223.27
200-day average
$224.13
Next earnings
Feb 3
Shares outstanding
97.11M
52-week range
$195.14$269.44

STERIS plc (Ireland) swing-trade checklist

STERIS plc (Ireland) scores 2 supportive, 3 mixed and 1 headwind across the 6 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive3 mixed1 headwind

  • Trendmixed

    Averages disagree

    Close $264.32 sits between the 50-day ($223.27) and 200-day ($224.13) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    47, Neutral

    Reading 47 is in the Neutral zone.

    See the GekkoIndex
  • Fair valueheadwind

    5.5% above

    Price is 5.5% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 90 days: Congress 1 buy / 0 sales.

    See smart money
  • Earnings risksupportive

    Reports in 80 days

    Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitymixed

    +2.5% on average

    From this point in the calendar, the next 20 trading days averaged +2.5% over 5 years, rising in 2 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

STERIS plc (Ireland) stock chart and price history

STERIS plc (Ireland) closed at $264.32 on Nov 13, 2026, −1.4% over the past year, inside a 52-week range of $195.14 to $269.44.

Close50-day average200-day averageVolume
STERIS plc (Ireland) share price, past year, with 50-day and 200-day moving averages and volume$200$220$240DecJan 2026FebMarAprMayJunJulAugSepOctNov264.32

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+17.8%
3 months
+15.0%
6 months
+24.6%
1 year
−1.4%
The full STE chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open STE in Gekko

Follow STERIS plc (Ireland) through every session

Put STE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track STE in GekkoFree for 7 days. No credit card required.

About STERIS plc (Ireland)

STERIS plc focuses on keeping medical and laboratory settings free of contamination, offering goods and services tied to infection control across the United States, Ireland, and other markets. Its offerings span cleaning chemicals, products that confirm sterility, systems for reprocessing endoscopes automatically, and equipment such as surgical tables and lighting, along with tools that connect devices within a facility.

Work at the company is divided into three areas: Healthcare, Applied Sterilization Technologies, and Life Sciences. On top of selling equipment, STERIS handles upkeep of machines, repairs instruments, and sterilizes items under contract for firms that make medical devices and pharmaceutical products.

The company is incorporated in Ireland, and investors can trade its stock on the NYSE, where it carries the ticker STE.

Listed
NYSE
Sector
Health technology
Industry
Medical specialties
Website
steris.com

STERIS plc (Ireland) GekkoIndex: the smart money zone

STERIS plc (Ireland)’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 47, in the Neutral zone, up 6.4 points over five sessions.

010047Neutral

Up 6.4 points over five sessions, from the Distribution zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying37+0.3%+1.0%+7.0%+5.2%
Accumulation263+0.2%+0.7%+1.2%+2.0%
Neutral (current zone)371+0.2%−0.1%−0.7%−1.3%
Distribution30−1.7%−1.3%−2.9%−4.0%
Selling1Too few readings yet

Average STE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the STE price, zone by zone.Track STE in Gekko

Is STERIS plc (Ireland) stock overvalued? Gekko Fair Value

STERIS plc (Ireland) trades 5.5% above Gekko Fair Value of $250.51, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what STERIS plc (Ireland) shares are worth, recalculated every trading day.

$250.51

Gekko Fair Value, Nov 14, 2026

5.5% Overvalued

At the end of Aug 2026 the price was 7.3% below the estimate.

Gekko Fair ValueShare price, month end
$251$264Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open STE in Gekko

STERIS plc (Ireland) insider and Congress trading

No open-market insider purchases were filed for STERIS plc (Ireland), and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for STE in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every STE insider filing, plotted on the chart in Gekko.Open STE in Gekko

Congress trades last 90 days

1trade disclosed: 1 purchase and 0 sales.

MemberTypeAmountDisclosed
Ro Khanna
House, CA, purchase
Purchase$1,001 - $15,000Oct 9
traded Sep 11

From congressional disclosures, which report amounts as ranges.

Buybacks

STERIS plc (Ireland) has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$100.4M
As a share of market cap
0.39%
Trailing four quarters
$340.3M

From company filings.

STERIS plc (Ireland) earnings: next date and track record

STERIS plc (Ireland) reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±4.6%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

−5.2%Nov ’24+2.8%Feb ’25+6.8%May ’25+5.5%Aug ’25+7.5%Nov ’25−6.8%Feb ’26+1.6%May ’26−0.5%Aug ’26

Last earnings call, Aug 5, 2026 AI summary

What they said
STERIS reported Q1 FY2027 total revenue growth of 7% (6% constant currency organic), driven by volume and 190bps of price. Gross margin expanded 70bps to 46%, while EBIT margin rose 100bps to 23.8%. EPS of $2.59 grew 11% YoY. Healthcare segment grew 6% organically, with services up 10% and consumables up 9%. Free cash flow was $279.6M, with $100M in share buybacks completed.
Guidance
Management did not provide explicit forward-looking targets in this excerpt. Healthcare backlog of $444M with 4% order growth signals continued demand. Full-year outlook commentary was referenced but not yet detailed in the provided transcript portion.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 5, 2026$2.59
est $2.49
+4.0%$1.50B
est $1.49B
+0.3%−0.5%
May 11, 2026$2.83
est $2.85
−0.7%$1.59B
est $1.59B
−0.4%+1.6%
Feb 4, 2026$2.53
est $2.53
0.0%$1.50B
est $1.48B
+1.0%−6.8%
Nov 5, 2025$2.47
est $2.35
+5.1%$1.46B
est $1.43B
+2.0%+7.5%
Aug 6, 2025$2.34
est $2.26
+3.5%$1.39B
est $1.36B
+2.1%+5.5%
May 14, 2025$2.74
est $2.60
+5.4%$1.48B
est $1.47B
+0.8%+6.8%
Feb 5, 2025$2.32
est $2.32
0.0%$1.37B
est $1.38B
−0.8%+2.8%
Nov 6, 2024$2.14
est $2.13
+0.5%$1.33B
est $1.33B
−0.1%−5.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

STERIS plc (Ireland) stock forecast and analyst price targets

Analysts’ average 12-month price target for STERIS plc (Ireland) is $270.71, +2.4% from the last close, from 4 firms rating the stock in the last 90 days.

$270.71consensus 12-month target, +2.4% from the last close
Low $275High $305
Buy4
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 4 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 13JefferiesBuy, upgraded$305+15.4%
Nov 6KeyBancBuy, reiterated$284+7.4%
Nov 6UBSBuy, maintained$290+9.7%
Nov 5Piper SandlerBuy, maintained$275+4.0%
Aug 17KeyBancBuy, maintained$269+1.8%
−0.7%average 20-day move after past Neutral readings
+2.5%average move over the next 20 trading days in the last 5 years
±2.9%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

STERIS plc (Ireland) seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, STERIS plc (Ireland) averaged +2.5% across the last 5 years, rising in 2 of them.

Next 20 trading days, by year

−2.4%2021+18.7%2022+0.6%2023−3.2%2024−1.7%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days0.0%2 of 5
Next 10 trading days−0.8%2 of 5
Next 15 trading days+0.7%2 of 5
Next 20 trading days+2.5%2 of 5
Next 30 trading days+2.6%3 of 5

For scale, STE’s typical 20-trading-day move in either direction is about 4.4%.

STERIS plc (Ireland) market cap and key statistics

STERIS plc (Ireland)’s market cap is $25.67B, with a P/E ratio of 30.4 and revenue of $6.17B over the last twelve months.

Valuation

Market cap
$25.67B
P/E ratio
30.4
Forward P/E
22.5
EPS, TTM
$8.34
Gekko Fair Value
$250.51

Trading

Volume
976,381
Avg volume, 20 days
864,236
52-week high
$269.44
52-week low
$195.14
Shares outstanding
97.11M

Financials

Revenue, TTM
$6.17B
Profit margin
13.4%
Return on equity
11.6%
Quarterly earnings growth, YoY
+12.9%

Risk and income

Beta
0.86
Typical daily move
±2.9%
Typical 20-day move
±4.4%
Dividend yield
1.01%

STERIS plc (Ireland) stock news this week

Coverage of STERIS plc (Ireland) this week reads positive: 8 positive, 7 neutral and 0 negative headlines.

News sentiment positive

STERIS plc (Ireland) peers

STERIS plc (Ireland)’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

STERIS plc (Ireland) stock FAQ

What is STERIS plc (Ireland)’s market cap?

STERIS plc (Ireland)’s market cap is $25.67B at the Nov 13, 2026 close of $264.32, with 97.11M shares outstanding. The shares trade on a P/E ratio of 30.4.

What is the STERIS plc (Ireland) stock forecast?

The consensus analyst 12-month price target for STERIS plc (Ireland) is $270.71, +2.4% from the last close. Of the 4 firms that rated the stock in the last 90 days, 4 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is STERIS plc (Ireland) stock overvalued or undervalued?

On Gekko’s estimate STERIS plc (Ireland) is overvalued: the Nov 13, 2026 close of $264.32 is 5.5% above Gekko Fair Value of $250.51. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does STERIS plc (Ireland) report earnings next?

STERIS plc (Ireland) is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $2.80 per share on revenue of $1.60B. STERIS plc (Ireland) beat the earnings estimate in 5 of its last 8 reports, moving 4.6% on average across the report.

What is STERIS plc (Ireland)’s 52-week high and low?

STERIS plc (Ireland)’s 52-week high is $269.44 and its 52-week low is $195.14; it closed at $264.32 on Nov 13, 2026, −1.4% over the past year.

Is STERIS plc (Ireland) stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (smart money and earnings risk), 3 as mixed (trend, gekkoindex and seasonality) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See STERIS plc (Ireland) the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.